Acute Therapies

Market Development |||| d Baxter Initiative Evidence Generation Peer-to-Peer Educational Programs Reimbursement Enablement Investment $20M Invested across multiple programs globally Portfolio Innovation Enter ¿A Development Adjacencies + Result 6 claims established on PrisMax Ongoing studies to generate additional claims Live training with >3,000 HCPs across all major markets in 2017 Increasing adoption in multiple markets (US, China, Poland and others) Global CRRT Penetration Increasing From 40% to 44% From 2018 - 2023 | 9

View entire presentation